These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 22163128)
1. Altered systemic ketone body metabolism in advanced heart failure. Janardhan A; Chen J; Crawford PA Tex Heart Inst J; 2011; 38(5):533-8. PubMed ID: 22163128 [TBL] [Abstract][Full Text] [Related]
2. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling. Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098 [TBL] [Abstract][Full Text] [Related]
3. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study. Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634 [TBL] [Abstract][Full Text] [Related]
4. Myocardial ketone body utilization in patients with heart failure: The impact of oral ketone ester. Monzo L; Sedlacek K; Hromanikova K; Tomanova L; Borlaug BA; Jabor A; Kautzner J; Melenovsky V Metabolism; 2021 Feb; 115():154452. PubMed ID: 33248064 [TBL] [Abstract][Full Text] [Related]
5. Role of ketone bodies in perinatal myocardial energy metabolism. Bartelds B; van der Leij FR; Kuipers JR Biochem Soc Trans; 2001 May; 29(Pt 2):325-30. PubMed ID: 11356176 [TBL] [Abstract][Full Text] [Related]
6. Treatments for skeletal muscle abnormalities in heart failure: sodium-glucose transporter 2 and ketone bodies. Takada S; Sabe H; Kinugawa S Am J Physiol Heart Circ Physiol; 2022 Feb; 322(2):H117-H128. PubMed ID: 34860594 [TBL] [Abstract][Full Text] [Related]
7. Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. Bedi KC; Snyder NW; Brandimarto J; Aziz M; Mesaros C; Worth AJ; Wang LL; Javaheri A; Blair IA; Margulies KB; Rame JE Circulation; 2016 Feb; 133(8):706-16. PubMed ID: 26819374 [TBL] [Abstract][Full Text] [Related]
8. Blood ketone bodies in congestive heart failure. Lommi J; Kupari M; Koskinen P; Näveri H; Leinonen H; Pulkki K; Härkönen M J Am Coll Cardiol; 1996 Sep; 28(3):665-72. PubMed ID: 8772754 [TBL] [Abstract][Full Text] [Related]
9. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811 [TBL] [Abstract][Full Text] [Related]
11. [Potential implications of ketone body metabolism changes and ketogenic therapy in the treatment of heart failure]. Wang Q; Yan S; Kuang S; Zhou M; Jiang C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):769-772. PubMed ID: 37545460 [TBL] [Abstract][Full Text] [Related]
12. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure. Nambu H; Takada S; Fukushima A; Matsumoto J; Kakutani N; Maekawa S; Shirakawa R; Nakano I; Furihata T; Katayama T; Yamanashi K; Obata Y; Saito A; Yokota T; Kinugawa S Eur J Pharmacol; 2020 Jan; 866():172810. PubMed ID: 31738936 [TBL] [Abstract][Full Text] [Related]
13. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Dhainaut JF; Huyghebaert MF; Monsallier JF; Lefevre G; Dall'Ava-Santucci J; Brunet F; Villemant D; Carli A; Raichvarg D Circulation; 1987 Mar; 75(3):533-41. PubMed ID: 3815765 [TBL] [Abstract][Full Text] [Related]
16. The unusual energy metabolism of elasmobranch fishes. Speers-Roesch B; Treberg JR Comp Biochem Physiol A Mol Integr Physiol; 2010 Apr; 155(4):417-34. PubMed ID: 19822221 [TBL] [Abstract][Full Text] [Related]
17. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. Massie BM; Simonini A; Sahgal P; Wells L; Dudley GA J Am Coll Cardiol; 1996 Jan; 27(1):140-5. PubMed ID: 8522687 [TBL] [Abstract][Full Text] [Related]
18. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. Hambrecht R; Niebauer J; Fiehn E; Kälberer B; Offner B; Hauer K; Riede U; Schlierf G; Kübler W; Schuler G J Am Coll Cardiol; 1995 May; 25(6):1239-49. PubMed ID: 7722116 [TBL] [Abstract][Full Text] [Related]
19. [Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure]. Huonker M; Keul J Z Kardiol; 2001 Nov; 90(11):813-23. PubMed ID: 11771449 [TBL] [Abstract][Full Text] [Related]
20. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure. Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]